CENTIVAX
CENTIVAX
Industry:
Biotechnology Health Care Health Diagnostics Medical
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.centivax.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
Aidar Health
Aidar Health is a healthcare technology and digital therapeutics company.
NMMC
North mississippi medical centre is an medical centre providing acute diagnostic and therapeutic services
Oncology Hematology Care
Oncology Hematology Care provides immunotherapy, medical oncology, radiation, hormone therapy, cancer screenings & nurse navigator services.
PT Diagnos Laboratorium Utama
Diagnos Lab is a health servicer that provides blood tests, pharmaceutical warehouses, blood & sperm banks & other medical support services.
Current Employees Featured
Official Site Inspections
http://www.centivax.com Semrush global rank: 8.76 M Semrush visits lastest month: 261
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Centivax" on Search Engine
Centivax CEO Jacob Glanville: "Weโre in the Vaccine โฆ
Dec 16, 2022 Jacob Glanville, PhD, CEO and president of Centivax, discussed his companyโs focus on COVID-19, timing of future clinical trials, and plans to pursue Series A capital in an exclusive interview...See details»
Centivax | LinkedIn
About us. Smash the mutants. Website. http://www.centivax.com. Industry. Biotechnology. Company size. 11-50 employees. Headquarters. South San Francisco, CA. Type. โฆSee details»
This Biotech Entrepreneur Just Raised $10 Million To โฆ
Nov 16, 2022 Centivax Distributed Bio cofounder Jacob Glanvilleโs new venture, Centivax, just raised a seed round to lay a foundation for โฆSee details»
Centivax - Crunchbase Company Profile & Funding
About. Centivax is a healthcare-based agency that provides biotechnology, pharmaceutical, medical device manufacturing, and therapeutic services. South San Francisco, โฆSee details»
Biotechnology Company Centivax Officially Launches - PR โฆ
SAN FRANCISCO, April 29, 2021 /PRNewswire/ -- Centivax Inc. is proud to announce its launch on Jan. 1, 2021, as a fully independent biotechnology company developing broad โฆSee details»
Wide Shot: Jacob Glanville Pursues Broad-Spectrum โฆ
Dec 15, 2022 Centivax targets flu, COVID-19, HIV, and 14 other pathogens with platform designed to overcome rapid mutations. December 14, 2022. Jacob Glanville, PhD, Centivaxโs CEO and President, says his...See details»
Centivax Drives Next-Generation COVID-19 Antibody โฆ
May 20, 2021 Centivax was initially a therapeutics spinout of Distributed Bio, a contract research organization. Earlier this year, Glanville sold Distributed Bio, to Charles River Laboratories for $83 million in upfront โฆSee details»
Centivax Antibodies Neutralize the Pandemic Coronavirus, โฆ
May 18, 2020 SOUTH SAN FRANCISCO, Calif.-- ( BUSINESS WIRE )-- Centivax Inc, the therapeutics spin-out of Contract Research Organization Distributed Bio Inc, โฆSee details»
Centivax Antibody Effective in Reducing COVID-19 Lung โฆ
Jul 16, 2020 SOUTH SAN FRANCISCO, Calif.-- ( BUSINESS WIRE )-- Centivax Inc, the therapeutics spinout of Contract Research Organization Distributed Bio Inc, announced โฆSee details»
Preparing for the next plague | Nature Biotechnology
Nov 19, 2021 Centivax will be taking its first product, CENT-B9 for SARS-CoV-2, into clinical trials later this year, with funding from US Naval Medical Research Center, which โฆSee details»
Centivax and US Naval Medical Research Center to begin Phase โฆ
Jun 3, 2021 Centivax Inc. announced today that it has entered into a strategic partnership with the U.S. Naval Medical Research Center (NMRC) for Phase I clinical development โฆSee details»
Charles River Labs Acquires Antibody Partner Distributed Bio for โฆ
Jan 5, 2021 In January 2020, Distributed Bio spun out Centivax, a company focused on developing the universal vaccine and COVID-19 therapeutics as part of a portfolio that โฆSee details»
Centivax - Funding, Financials, Valuation & Investors - Crunchbase
Centivax has raised a total of. $14.2M. in funding over 2 rounds. Their latest funding was raised on Nov 16, 2022 from a Seed round. Centivax is funded by 3 investors. NFX and โฆSee details»
Centivax Licenses Anti-COVID-19 Antibodies to Thermo Fisher
Oct 20, 2020 Biodetection. Centivax Licenses Anti-COVID-19 Antibodies to Thermo Fisher. By Global Biodefense Staff October 20, 2020. Centivax Inc, the therapeutics โฆSee details»
Biotechnology Company Centivax Officially Launches
SAN FRANCISCO, April 29, 2021 /PRNewswire/ -- Centivax Inc. is proud to announce its launch on Jan. 1, 2021, as a fully independent biotechnology company developing broad โฆSee details»
Centivax signs licensing agreement with Therm | EurekAlert!
Centivax Inc, the therapeutics spinout of Contract Research Organization Distributed Bio Inc, announced today a licensing agreement with Thermo Fisher Scientific.See details»
Centivax - Updates, News, Events, Signals & Triggers - Crunchbase
Jan 18, 2024 Centivax is a healthcare-based agency that provides biotechnology, pharmaceutical, medical device manufacturing, and therapeutic services.See details»
Centivax, Inc. - BIO International Convention 2024
Founded by leading experts in pharmaceutical development, immunology, vaccine science, computational biology, and broadly neutralizing antibody engineering, Centivax is on a โฆSee details»
Centivax - BIO International Convention | BIO
Jun 5, 2023 California. Company HQ Country: United States. Year Founded: 2019. Main Therapeutic Focus: Infectious Diseases. Lead Product in Development: Centi-Flu. โฆSee details»
Centivax Antibodies Neutralize the Pandemic Coronavirus
Published: May 18, 2020. SOUTH SAN FRANCISCO, Calif.-- ( BUSINESS WIRE )-- Centivax Inc, the therapeutics spin-out of Contract Research Organization Distributed โฆSee details»